Literature DB >> 18239958

Association of increased active PTH(1-84) fraction with decreased GFR and serum Ca in predialysis CRF patients: modulation by serum 25-OH-D.

M Kurajoh1, M Inaba, S Yamada, Y Imanishi, T Tsuchida, E Ishimura, Y Nishizawa.   

Abstract

UNLABELLED: As the serum calcium and glomerular filtration rate decreased, the proportion of active PTH(1-84) molecules in PTH immunoreactivity increased in serum from predialysis uremic patients, particularly those with vitamin D insufficiency.
INTRODUCTION: The PTH(1-84) fraction was altered in predialysis patients with chronic renal failure (CRF).
METHODS: Serum PTH in predialysis CRF patients without any medication was measured by PTH(1-84)-specific whole PTH assay and intact PTH assay cross-reacting with N-truncated PTH.
RESULTS: In CRF patients, the glomerular filtration rate (GFR) correlated positively with serum Ca and 1,25-dihydroxyvitamin D (1,25(OH)(2)D), and inversely with serum Pi, log intact PTH, and log whole PTH. In multiple regression analysis, including age, gender, body mass index, GFR, Ca, and Pi and 1,25(OH)(2)D as independent variables, serum Ca and GFR associated significantly with serum log whole PTH and intact PTH. Serum log whole PTH/intact PTH ratio, which increased as serum Ca and GFR decreased, retained a negative correlation in those with serum 25-hydroxyvitamin D levels below 20 ng/ml, but not in those above 20 ng/ml. The ratio also correlated positively with serum log tartrate-resistant acid-phosphatase-5b, log cross-linked N-telopeptide of type-I collagen, and log bone alkaline-phosphatase.
CONCLUSION: As GFR declined with suppression of serum Ca, the proportion of active PTH molecules increased in predialysis CRF patients, particularly those with vitamin D insufficiency.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18239958     DOI: 10.1007/s00198-007-0554-2

Source DB:  PubMed          Journal:  Osteoporos Int        ISSN: 0937-941X            Impact factor:   4.507


  31 in total

1.  Technical and clinical characterization of the Bio-PTH (1-84) immunochemiluminometric assay and comparison with a second-generation assay for parathyroid hormone.

Authors:  Masaaki Inaba; Kiyoshi Nakatsuka; Yasuo Imanishi; Masakazu Watanabe; Yuji Mamiya; Eiji Ishimura; Yoshiki Nishizawa
Journal:  Clin Chem       Date:  2003-12-18       Impact factor: 8.327

2.  25-Hydroxyvitamin D(3) suppresses PTH synthesis and secretion by bovine parathyroid cells.

Authors:  C S Ritter; H J Armbrecht; E Slatopolsky; A J Brown
Journal:  Kidney Int       Date:  2006-08       Impact factor: 10.612

3.  Poor glycemic control impairs the response of biochemical parameters of bone formation and resorption to exogenous 1,25-dihydroxyvitamin D3 in patients with type 2 diabetes.

Authors:  M Inaba; Y Nishizawa; K Mita; Y Kumeda; M Emoto; T Kawagishi; E Ishimura; K Nakatsuka; A Shioi; H Morii
Journal:  Osteoporos Int       Date:  1999       Impact factor: 4.507

4.  Development of a novel fragments absorbed immunocapture enzyme assay system for tartrate-resistant acid phosphatase 5b.

Authors:  Tatsuya Ohashi; Yoshihiko Igarashi; Yoshiko Mochizuki; Toshihide Miura; Noriyuki Inaba; Katsuhiro Katayama; Takeshi Tomonaga; Fumio Nomura
Journal:  Clin Chim Acta       Date:  2006-08-25       Impact factor: 3.786

5.  Protective effect of an aldose reductase inhibitor against bone loss in galactose-fed rats: possible involvement of the polyol pathway in bone metabolism.

Authors:  M Inaba; M Terada; Y Nishizawa; A Shioi; E Ishimura; S Otani; H Morii
Journal:  Metabolism       Date:  1999-07       Impact factor: 8.694

6.  A novel immunoradiometric assay detects full-length human PTH but not amino-terminally truncated fragments: implications for PTH measurements in renal failure.

Authors:  M R John; W G Goodman; P Gao; T L Cantor; I B Salusky; H Jüppner
Journal:  J Clin Endocrinol Metab       Date:  1999-11       Impact factor: 5.958

7.  Evidence that serum phosphate is independently associated with serum PTH in patients with chronic renal failure.

Authors:  D M Kates; D J Sherrard; D L Andress
Journal:  Am J Kidney Dis       Date:  1997-12       Impact factor: 8.860

8.  Significance of Bio-intact PTH(1-84) assay in hemodialysis patients.

Authors:  Masaaki Inaba; Senji Okuno; Yasuo Imanishi; Misako Ueda; Tomoyuki Yamakawa; Eiji Ishimura; Yoshiki Nishizawa
Journal:  Osteoporos Int       Date:  2004-08-20       Impact factor: 4.507

9.  Application of a new serum assay for type I collagen cross-linked N-telopeptides: assessment of diurnal changes in bone turnover with and without alendronate treatment.

Authors:  B J Gertz; J D Clemens; S D Holland; W Yuan; S Greenspan
Journal:  Calcif Tissue Int       Date:  1998-08       Impact factor: 4.333

10.  24R,25-dihydroxyvitamin D3 increases cyclic GMP contents, leading to an enhancement of osteocalcin synthesis by 1,25-dihydroxyvitamin D3 in cultured human osteoblastic cells.

Authors:  T Yamamoto; K Ozono; M Shima; K Yamaoka; S Okada
Journal:  Exp Cell Res       Date:  1998-10-10       Impact factor: 3.905

View more
  10 in total

1.  Increased active PTH(1-84) fraction as a predictor of poor mortality in male hemodialysis patients.

Authors:  M Inaba; S Okuno; Y Imanishi; E Ishimura; T Yamakawa; S Shoji
Journal:  Osteoporos Int       Date:  2013-09-13       Impact factor: 4.507

2.  Reduction of whole PTH/intact PTH ratio as a predictor of bone metabolism in cinacalcet treatment of hemodialysis patients with secondary hyperparathyroidism.

Authors:  M Kurajoh; M Inaba; S Okuno; H Nagayama; S Yamada; Y Imanishi; E Ishimura; S Shoji; T Yamakawa; Y Nishizawa
Journal:  Osteoporos Int       Date:  2010-05-07       Impact factor: 4.507

3.  Changes in bone mineral parameters, vitamin D metabolites, and PTH measurements with varying chronic kidney disease stages.

Authors:  Sanjeev Patel; Jeffrey L Barron; Mehdi Mirzazedeh; Hugh Gallagher; Steve Hyer; Tom Cantor; William D Fraser
Journal:  J Bone Miner Metab       Date:  2010-06-03       Impact factor: 2.626

4.  Factors affecting postoperative activities of daily living in patients with osteoporotic vertebral collapse with neurological deficits.

Authors:  Masafumi Kashii; Ryoji Yamazaki; Tomoya Yamashita; Shinya Okuda; Takahito Fujimori; Yukitaka Nagamoto; Yuichi Tamura; Takenori Oda; Tetsuo Ohwada; Motoki Iwasaki; Hideki Yoshikawa
Journal:  J Bone Miner Metab       Date:  2014-07-06       Impact factor: 2.626

5.  Determination of NF-κB and RANKL levels in peripheral blood osteoclast precursor cells in chronic kidney disease patients.

Authors:  Gülcan Güneş; Nil Doğruer Ünal; Gülçin Eskandari; Ahmet Kiykim; Özlem Bölgen Çimen; Gülhan Temel; Mehmet Burak Y Çimen
Journal:  Int Urol Nephrol       Date:  2018-04-11       Impact factor: 2.370

6.  Decreased cortical thickness, as estimated by a newly developed ultrasound device, as a risk for vertebral fracture in type 2 diabetes mellitus patients with eGFR of less than 60 mL/min/1.73 m2.

Authors:  T Mishima; K Motoyama; Y Imanishi; K Hamamoto; Y Nagata; S Yamada; N Kuriyama; Y Watanabe; M Emoto; M Inaba
Journal:  Osteoporos Int       Date:  2014-09-04       Impact factor: 4.507

7.  Association of BAP with urinary albumin excretion in postmenopausal, but not premenopausal, non-CKD Japanese women.

Authors:  Etsuko Ozaki; Shinsuke Yamada; Nagato Kuriyama; Daisuke Matsui; Isao Watanabe; Teruhide Koyama; Yasuo Imanishi; Masaaki Inaba; Yoshiyuki Watanabe
Journal:  Sci Rep       Date:  2018-01-08       Impact factor: 4.379

8.  Significance of urinary C-megalin excretion in vitamin D metabolism in pre-dialysis CKD patients.

Authors:  Norikazu Toi; Masaaki Inaba; Eiji Ishimura; Naoko Tsugawa; Yasuo Imanishi; Masanori Emoto; Yoshiaki Hirayama; Shinya Nakatani; Akihiko Saito; Shinsuke Yamada
Journal:  Sci Rep       Date:  2019-02-18       Impact factor: 4.379

9.  Inverse association of plasma leptin with cortical thickness at distal radius determined with a quantitative ultrasound device in patients with type 2 diabetes mellitus.

Authors:  Masafumi Kurajoh; Masaaki Inaba; Koka Motoyama; Nagato Kuriyama; Etsuko Ozaki; Teruhide Koyama; Shinsuke Yamada; Tomoaki Morioka; Yasuo Imanishi; Masanori Emoto
Journal:  J Diabetes Investig       Date:  2019-06-05       Impact factor: 4.232

10.  Comparison of Second- and Third-Generation Parathyroid Hormone Test Results in Patients with Chronic Kidney Disease.

Authors:  Magdalena Wójtowicz; Wiesław Piechota; Zofia Wańkowicz; Jerzy Smoszna; Stanisław Niemczyk
Journal:  Med Sci Monit       Date:  2020-12-24
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.